Authors:
Arca, M
Montali, A
Ombres, D
Battiloro, E
Campagna, F
Ricci, G
Verna, R
Citation: M. Arca et al., Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis, CLIN GENET, 60(5), 2001, pp. 374-380
Authors:
De Sarro, G
Carotti, A
Campagna, F
McKernan, R
Rizzo, M
Falconi, U
Palluotto, F
Giusti, P
Rettore, C
De Sarro, A
Citation: G. De Sarro et al., Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones in mice, PHARM BIO B, 65(3), 2000, pp. 475-487
Authors:
Arca, M
Campagna, F
Montali, A
Barilla, F
Mangieri, E
Tanzilli, G
Seccareccia, F
Campa, PP
Ricci, G
Pannitteri, G
Citation: M. Arca et al., The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis, CLIN GENET, 58(5), 2000, pp. 369-374
Authors:
Zuliani, G
Arca, M
Signore, A
Bader, G
Fazio, S
Chianelli, M
Bellosta, S
Campagna, F
Montali, A
Maioli, M
Pacifico, A
Ricci, G
Fellin, R
Citation: G. Zuliani et al., Characterization of a new form of inherited hypercholesterolemia - Familial recessive hypercholesterolemia, ART THROM V, 19(3), 1999, pp. 802-809
Authors:
Baroni, MG
D'Andrea, MP
Montali, A
Pannitteri, G
Barilla, F
Campagna, F
Mazzei, E
Lovari, S
Seccareccia, F
Campa, PP
Ricci, G
Pozzilli, P
Urbinati, G
Arca, M
Citation: Mg. Baroni et al., A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease, ART THROM V, 19(12), 1999, pp. 2975-2980
Authors:
Campagna, F
Palluotto, F
Carotti, A
Casini, G
Genchi, G
Citation: F. Campagna et al., Synthesis and structure-affinity relationships at the central benzodiazepine receptor of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines, BIO MED CH, 7(8), 1999, pp. 1533-1538
Authors:
Palluotto, F
Carotti, A
Casini, G
Ferappi, M
Rosato, A
Vitali, C
Campagna, F
Citation: F. Palluotto et al., Synthesis and antibacterial activity of 2-aryl-2, 5-dibydro-3(3H)-oxo-pyridazino[4,3-b]indole-4-carboxylic acids, FARMACO, 54(3), 1999, pp. 191-194